AR122805A1 - HER2 MUTATION INHIBITORS - Google Patents
HER2 MUTATION INHIBITORSInfo
- Publication number
- AR122805A1 AR122805A1 ARP210101822A ARP210101822A AR122805A1 AR 122805 A1 AR122805 A1 AR 122805A1 AR P210101822 A ARP210101822 A AR P210101822A AR P210101822 A ARP210101822 A AR P210101822A AR 122805 A1 AR122805 A1 AR 122805A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- her2 mutation
- salts
- mutation inhibitors
- enantiomers
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos de la fórmula (1), y enantiómeros de estos, y a sales farmacéuticamente aceptables de la fórmula (1) y dichos enantiómeros, en donde L¹, L², R¹, R², R³ y n son como se definen en el presente documento. Además composiciones farmacéuticas que comprenden dichos compuestos y sales, y métodos y usos de dichos compuestos, sales y composiciones para el tratamiento del crecimiento celular anormal, incluido el cáncer, en un sujeto que lo necesite.Compounds of formula (1), and enantiomers thereof, and pharmaceutically acceptable salts of formula (1) and said enantiomers, wherein L¹, L², R¹, R², R³ and n are as defined herein. Furthermore pharmaceutical compositions comprising said compounds and salts, and methods and uses of said compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063046506P | 2020-06-30 | 2020-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR122805A1 true AR122805A1 (en) | 2022-10-05 |
Family
ID=83835076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210101822A AR122805A1 (en) | 2020-06-30 | 2021-06-29 | HER2 MUTATION INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR122805A1 (en) |
-
2021
- 2021-06-29 AR ARP210101822A patent/AR122805A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38553A (en) | CDK2 INHIBITORS | |
| CO2021017504A2 (en) | Benzisoxazole Sulfonamide Derivatives | |
| ECSP20067394A (en) | CYCLINE-DEPENDENT KINASE INHIBITORS | |
| CL2021001190A1 (en) | Azalactam compounds as inhibitors of hpk1 | |
| CL2019000368A1 (en) | CDK2 / 4/6 inhibitors. | |
| CO2022008091A2 (en) | kras g12c inhibitors | |
| UY37900A (en) | NEW DERIVATIVES OF RAPAMYCIN | |
| ECSP22033597A (en) | SMALL MOLECULE INHIBITORS OF KRAS MUTANT G12C | |
| DOP2023000281A (en) | HER2 MUTATION INHIBITORS | |
| DOP2024000039A (en) | QUINOLINE DERIVATIVES AS ALFA4BETA7 INTEGRIN INHIBITORS | |
| CO2017009891A2 (en) | Inhibitors of transforming growth factor beta inhibitors (tgf-beta) | |
| PE20142339A1 (en) | MACROCYCLICAL DERIVATIVES FOR THE TREATMENT OF DISEASES | |
| CL2022003007A1 (en) | Azalactam compounds as hpk1 inhibitors | |
| CL2023003275A1 (en) | Allosteric inhibitors of chromenone phosphoinositide 3-kinase (pi3k) for the treatment of diseases. | |
| CR20140399A (en) | PIRROLIDINA-2-SUBSTITUTED CARBOXAMIDS | |
| PE20231651A1 (en) | COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH BRAF | |
| UY39303A (en) | HER2 MUTATION INHIBITORS | |
| UY39517A (en) | BTK INHIBITORS | |
| AR122805A1 (en) | HER2 MUTATION INHIBITORS | |
| DOP2022000203A (en) | 3-PHENOXIAZETIDIN-1-SUBSTITUTED IL-PYRAZINES WITH GPR52 ANTAGONIST ACTIVITY | |
| AR126238A1 (en) | HER2 MUTATION INHIBITORS |